Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 00:30 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 6,351 | $1.23 | $7,811.73 |
DisclosureSEC source: 0001492256-26-000009 · form4-10012026_041003.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,161 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on September 30, 2026 of $1.23 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on September 30, 2026 of $1.23 per share. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 21:45 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 6,103 | $1.28 | $7,811.84 |
DisclosureSEC source: 0001492256-26-000007 · form4-07012026_090708.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,810 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on June 30, 2026 of $1.28 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on June 30, 2026 of $1.28 per share. Read SEC document |
| May 20, 2026 Filed May 26, 2026 23:45 UTC |
Spiegel Robert J.Director
|
GrantStock Option (right to buy) · Derivative | 220,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001492256-26-000006 · form4-05262026_070511.xml · derivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2036-05-19 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 20, 2026 Filed May 26, 2026 23:45 UTC |
O'Farrell Elizabeth G.Director
|
GrantStock Option (right to buy) · Derivative | 220,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001744662-26-000006 · form4-05262026_070508.xml · derivative · entry 1 O'Farrell Elizabeth G. · CIK 0001744662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2036-05-19 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 20, 2026 Filed May 26, 2026 23:45 UTC |
Molineaux SusanDirector
|
GrantStock Option (right to buy) · Derivative | 220,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001553389-26-000002 · form4-05262026_070505.xml · derivative · entry 1 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2036-05-19 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 20, 2026 Filed May 26, 2026 23:45 UTC |
Bir Dawn CarterDirector
|
GrantStock Option (right to buy) · Derivative | 220,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001688712-26-000003 · form4-05262026_070502.xml · derivative · entry 1 Bir Dawn Carter · CIK 0001688712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2036-05-19 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 20, 2026 Filed May 26, 2026 23:45 UTC |
McDonald John FDirector
|
GrantStock Option (right to buy) · Derivative | 220,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001944633-26-000002 · form4-05262026_070503.xml · derivative · entry 1 McDonald John F · CIK 0001944633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2036-05-19 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 00:14 UTC |
Williams TimothyEVP and Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,500,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001748392-26-000005 · form4-04152026_120410.xml · derivative · entry 1 Williams Timothy · CIK 0001748392 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common Stock · 2,500,000 shares Expires 2036-04-12 F1 · derivative.exercise_date: This option vests as follows: 312,500 shares underlying the option will vest on October 13, 2026; and the remaining shares will vest over the following 42 months in equal installments, provided that the Reporting Person provides continuous service to the Issuer on each such vesting date. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 20:30 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 5,243 | $1.49 | $7,812.07 |
DisclosureSEC source: 0001492256-26-000004 · form4-04012026_040401.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,707 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on March 31, 2026 of $1.49 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on March 31, 2026 of $1.49 per share. Read SEC document |
| March 25, 2026 Filed Mar 26, 2026 21:37 UTC |
Chinoporos ConstantineDirector
|
GrantStock Option (Right to Buy) · Derivative | 270,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0002014509-26-000003 · form4-03262026_090305.xml · derivative · entry 1 Chinoporos Constantine · CIK 0002014509 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,000 Underlying: Common Stock · 270,000 shares Expires 2036-03-24 F1 · derivative.exercise_date: The option shall vest and become exercisable in three equal annual installments starting on March 25, 2027, subject to the Reporting Person's continuous service (as defined in the Issuer's 2018 Equity Incentive Plan) with the Issuer through each such vesting date. Read SEC document |
| March 25, 2026 Filed Mar 26, 2026 21:33 UTC |
Andrews Patricia SDirector
|
GrantStock Option (Right to Buy) · Derivative | 270,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001445710-26-000004 · form4-03262026_090309.xml · derivative · entry 1 Andrews Patricia S · CIK 0001445710 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,000 Underlying: Common Stock · 270,000 shares Expires 2036-03-24 F1 · derivative.exercise_date: The option shall vest and become exercisable in three equal annual installments starting on March 25, 2027, subject to the Reporting Person's continuous service (as defined in the Issuer's 2018 Equity Incentive Plan) with the Issuer through each such vesting date. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 23:10 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 27,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001755098-26-000001 · form4-02192026_110201.xml · derivative · entry 4 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 27,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. F5 · derivative.expiration_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 23:10 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 9,855 | $1.94 | $19,118.70 |
DisclosureSEC source: 0001755098-26-000001 · form4-02192026_110201.xml · nonDerivative · entry 2 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,645 F2 · kind: Represents shares of common stock sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to mandatory "sell to cover" policies maintained by the Issuer and provisions contained in the Reporting Person's applicable RSU agreement, and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 23:10 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 27,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001755098-26-000001 · form4-02192026_110201.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Shares of common stock acquired upon the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 23:11 UTC |
Eid JosephEVP, R&D; Chief Medical Office
|
GrantStock Option (Right to Buy) · Derivative | 2,220,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001780247-26-000001 · form4-02192026_110212.xml · derivative · entry 1 Eid Joseph · CIK 0001780247 · EVP, R&D; Chief Medical Office 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,220,000 Underlying: Common Stock · 2,220,000 shares Expires 2036-02-16 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments commencing on March 17, 2026, provided that the Reporting Person provides continuous service to the Issuer on each such vesting date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 23:10 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 1,660,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001755098-26-000001 · form4-02192026_110201.xml · derivative · entry 3 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,660,000 Underlying: Common Stock · 1,660,000 shares Expires 2036-02-16 F3 · derivative.exercise_date: The option vests in 48 equal monthly installments commencing on March 17, 2026, provided that the Reporting Person provides continuous service to the Issuer on each such vesting date. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:40 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 5,918 | $1.32 | $7,811.76 |
DisclosureSEC source: 0001492256-26-000003 · form4-01052026_050107.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,464 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on December 31, 2025 of $1.32 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on December 31, 2025 of $1.32 per share. Read SEC document |
| October 20, 2025 Filed Oct 20, 2025 21:35 UTC |
ElNawawi AhmedEVP, Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 3,000,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001628280-25-045549 · wk-form4_1760996100.xml · derivative · entry 1 ElNawawi Ahmed · CIK 0002091794 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2035-10-19 F1 · derivative.exercise_date: The options vest as follows: 375,000 shares on April 20, 2026, the remaining 2,625,000 shares in a series of 42 equal monthly installments commencing April 20, 2026, provided the optionee continues to provide services to the Company. Read SEC document |
| September 30, 2025 Filed Oct 1, 2025 20:38 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 5,702 | $1.37 | $7,811.74 |
DisclosureSEC source: 0001628280-25-043459 · wk-form4_1759351083.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,546 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on September 30, 2025 of $1.37 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on September 30, 2025 of $1.37 per share. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:15 UTC |
Semerjian HaroutDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 4,000,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0000886744-25-000062 · wk-form4_1754684133.xml · derivative · entry 2 Semerjian Harout · CIK 0001809747 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000,000 Underlying: Common Stock · 4,000,000 shares Expires 2035-08-06 F2 · derivative.exercise_date: The options vest as follows: 1,000,000 shares on August 7, 2026, the remaining 3,000,000 shares in a series of 36 equal monthly installments commencing August 7, 2026, provided the optionee continues to provide services to the Company. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:15 UTC |
Semerjian HaroutDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 7,000,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0000886744-25-000062 · wk-form4_1754684133.xml · derivative · entry 1 Semerjian Harout · CIK 0001809747 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000,000 Underlying: Common Stock · 7,000,000 shares Expires 2035-08-06 F1 · derivative.exercise_date: The options vest as follows: 875,000 shares on February 7, 2026, the remaining 6,125,000 shares in a series of 42 equal monthly installments commencing February 7, 2026, provided the optionee continues to provide services to the Company. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 20:53 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 5,540 | $1.41 | $7,811.40 |
DisclosureSEC source: 0000886744-25-000038 · wk-form4_1751403231.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,844 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on June 30, 2025 of $1.41 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on June 30, 2025 of $1.41 per share. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:07 UTC |
Aggarwal GauravDirector
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0000886744-25-000027 · wk-form4_1747948046.xml · derivative · entry 1 Aggarwal Gaurav · CIK 0001551965 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2035-05-20 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:06 UTC |
Bir Dawn CarterDirector · Interim President and CEO
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0000886744-25-000026 · wk-form4_1747947992.xml · derivative · entry 1 Bir Dawn Carter · CIK 0001688712 · Director · Interim President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2035-05-20 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:04 UTC |
LAWLIS V BRYANDirector
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0000886744-25-000025 · wk-form4_1747947876.xml · derivative · entry 1 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2035-05-20 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:03 UTC |
McDonald John FDirector
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0000886744-25-000024 · wk-form4_1747947806.xml · derivative · entry 1 McDonald John F · CIK 0001944633 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2035-05-20 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:02 UTC |
Molineaux SusanDirector
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0000886744-25-000023 · wk-form4_1747947757.xml · derivative · entry 1 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2035-05-20 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:01 UTC |
O'Farrell Elizabeth G.Director
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0000886744-25-000022 · wk-form4_1747947705.xml · derivative · entry 1 O'Farrell Elizabeth G. · CIK 0001744662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2035-05-20 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:00 UTC |
Spiegel Robert J.Director
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0000886744-25-000021 · wk-form4_1747947631.xml · derivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2035-05-20 F1 · derivative.exercise_date: This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:20 UTC |
LAWLIS V BRYANDirector
|
PurchaseCommon Stock | 13,300 | $1.18 | $15,667.40 |
DisclosureSEC source: 0000886744-25-000013 · wk-form4_1747167635.xml · nonDerivative · entry 1 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,300 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:30 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 4,913 | $1.59 | $7,811.67 |
DisclosureSEC source: 0000950170-25-049594 · ownership.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,304 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on March 31, 2025 of $1.59 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on March 31, 2025 of $1.59 per share. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 11:01 UTC |
Samuels Scott AlanEVP, Chief Legal Officer
|
PurchaseCommon Stock | 15,000 | $1.61 | $24,150.00 |
DisclosureSEC source: 0000950170-25-030330 · ownership.xml · nonDerivative · entry 1 Samuels Scott Alan · CIK 0001987259 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,682 F1 · kind: The reported transaction represents the open market purchase of 15,000 shares at an executed price of $1.61 per share. F2 · balance_after: The number of securities reported reflects the open market purchase of 15,000 shares and acquisition on June 30, 2024 of 7,432 shares and on December 31, 2024 of 4,250 shares of Geron common stock pursuant to the Employee Stock. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 11:01 UTC |
SCARLETT JOHN ADirector · Chairman, President and CEO
|
PurchaseCommon Stock | 12,500 | $1.77 | $22,062.50 |
DisclosureSEC source: 0000950170-25-030329 · ownership.xml · nonDerivative · entry 1 SCARLETT JOHN A · CIK 0001270928 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 F1 · kind: The reported transaction represents the open market purchase of 12,500 shares at an executed price of $1.765 per share. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 11:01 UTC |
Ziegler JamesEVP, Chief Commercial Officer
|
PurchaseCommon Stock | 100,000 | $1.60 | $160,000.00 |
DisclosureSEC source: 0000950170-25-030327 · ownership.xml · nonDerivative · entry 1 Ziegler James · CIK 0002035113 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · kind: The reported transaction represents the open market purchase of 100,000 shares at an executed price of $1.60 per share. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
SCARLETT JOHN ADirector · Chairman, President and CEO
|
GrantRestricted Stock Units · Derivative | 410,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-024132 · ownership.xml · derivative · entry 2 SCARLETT JOHN A · CIK 0001270928 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
SCARLETT JOHN ADirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 2,457,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0000950170-25-024132 · ownership.xml · derivative · entry 1 SCARLETT JOHN A · CIK 0001270928 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,457,000 Underlying: Common Stock · 2,457,000 shares Expires 2035-02-17 F1 · derivative.exercise_date: This option was granted on February 18, 2025 and vests in 48 consecutive equal monthly installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
Ziegler JamesEVP, Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 89,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-024130 · ownership.xml · derivative · entry 2 Ziegler James · CIK 0002035113 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,000 Underlying: Common Stock · 89,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
Ziegler JamesEVP, Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 529,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0000950170-25-024130 · ownership.xml · derivative · entry 1 Ziegler James · CIK 0002035113 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 529,000 Underlying: Common Stock · 529,000 shares Expires 2035-02-17 F1 · derivative.exercise_date: This option was granted on February 18, 2025 and vests as to 1/8th of the shares underlying the option on the sixth-month anniversary of the Reporting Person's date of hire of September 9, 2024, and as to the remaining shares underlying the option in 42 consecutive equal monthly installments thereafter, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
Samuels Scott AlanEVP, Chief Legal Officer
|
GrantRestricted Stock Units · Derivative | 104,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-024131 · ownership.xml · derivative · entry 2 Samuels Scott Alan · CIK 0001987259 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Stock · 104,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
Samuels Scott AlanEVP, Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 621,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0000950170-25-024131 · ownership.xml · derivative · entry 1 Samuels Scott Alan · CIK 0001987259 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 621,000 Underlying: Common Stock · 621,000 shares Expires 2035-02-17 F1 · derivative.exercise_date: This option was granted on February 18, 2025 and vests in 48 consecutive equal monthly installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
GRETHLEIN ANDREW JEVP, Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 140,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-024133 · ownership.xml · derivative · entry 2 GRETHLEIN ANDREW J · CIK 0001270921 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
GRETHLEIN ANDREW JEVP, Chief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 839,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0000950170-25-024133 · ownership.xml · derivative · entry 1 GRETHLEIN ANDREW J · CIK 0001270921 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 839,000 Underlying: Common Stock · 839,000 shares Expires 2035-02-17 F1 · derivative.exercise_date: This option was granted on February 18, 2025 and vests in 48 consecutive equal monthly installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
ROBERTSON MICHELLEEVP, Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-024129 · ownership.xml · derivative · entry 2 ROBERTSON MICHELLE · CIK 0001755098 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
ROBERTSON MICHELLEEVP, Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 656,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0000950170-25-024129 · ownership.xml · derivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 656,000 Underlying: Common Stock · 656,000 shares Expires 2035-02-17 F1 · derivative.exercise_date: This option was granted on February 18, 2025 and vests in 48 consecutive equal monthly installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 21:05 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 2,206 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-000409 · ownership.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,391 F1 · kind: Shares issued in lieu of cash payment for quarterly Board of Directors retainer fee. Number of shares issued based on the closing price of Geron common stock on December 31, 2024 of $3.54 per share. F1 · price: Shares issued in lieu of cash payment for quarterly Board of Directors retainer fee. Number of shares issued based on the closing price of Geron common stock on December 31, 2024 of $3.54 per share. Read SEC document |
| December 31, 2024 Filed Apr 2, 2025 21:10 UTC Amendment |
Spiegel Robert J.Director
|
GrantCommon Stock | 2,206 | $3.54 | $7,809.24 |
DisclosureSEC source: 0000950170-25-049554 · ownership.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,391 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on December 31, 2024 of $3.54 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on December 31, 2024 of $3.54 per share. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:05 UTC |
Eid JosephEVP, Research and Development
|
GrantStock Option (right to buy) · Derivative | 2,500,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000950170-24-125325 · ownership.xml · derivative · entry 1 Eid Joseph · CIK 0001780247 · EVP, Research and Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common Stock · 2,500,000 shares Expires 2034-11-10 F1 · derivative.exercise_date: The options vest as follows: 312,500 shares on May 11, 2025, the remaining 2,187,500 shares in series of 42 equal monthly installments commencing May 11, 2025, provided the optionee continues to provide services to the Company. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:05 UTC |
Spiegel Robert J.Director
|
GrantCommon Stock | 1,767 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-110796 · ownership.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,185 F1 · kind: Shares issued in lieu of cash payment for quarterly Board of Directors retainer fee. Number of shares issued based on close price of Geron common stock on September 30, 2024 of $4.54 per share. F1 · price: Shares issued in lieu of cash payment for quarterly Board of Directors retainer fee. Number of shares issued based on close price of Geron common stock on September 30, 2024 of $4.54 per share. Read SEC document |
| September 30, 2024 Filed Apr 2, 2025 21:05 UTC Amendment |
Spiegel Robert J.Director
|
GrantCommon Stock | 1,767 | $4.54 | $8,022.18 |
DisclosureSEC source: 0000950170-25-049544 · ownership.xml · nonDerivative · entry 1 Spiegel Robert J. · CIK 0001492256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,185 F1 · kind: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on September 30, 2024 of $4.54 per share. F1 · price: Shares issued in lieu of cash compensation for quarterly board of directors' retainer and committee fees. Number of shares issued based on the closing price of the Issuer's common stock on September 30, 2024 of $4.54 per share. Read SEC document |
| September 09, 2024 Filed Sep 9, 2024 20:35 UTC |
Ziegler JamesEVP, Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 1,600,000 | $0.00 Strike: $4.41 | $0.00 |
DisclosureSEC source: 0000950170-24-104788 · ownership.xml · derivative · entry 1 Ziegler James · CIK 0002035113 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600,000 Underlying: Common Stock · 1,600,000 shares Expires 2034-09-08 F1 · derivative.exercise_date: 1. The options vest as follows: 200,000 shares on March 9, 2025, the remaining 1,400,000 shares in series of 42 equal monthly installments commencing March 9, 2025, provided the optionee continues to provide services to the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.